Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab

Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab

Abstract Background Safely inhibiting the formation of scar in the glaucoma filtration surgery (GFS) has always been an issue for clinical glaucoma doctors. Anti-vascular endothelial growth factor (VEGF) agents can reduce angiogenesis, and anti-placental growth factor (PIGF) agents can affect reacti...

Full description

Bibliographic Details
Main Authors: Lei Zuo, Shaopin Zhu, Shengjie Gu, Xun Xu
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Ophthalmology
Subjects:
Anti-scarring
Bevacizumab
Conbercept
glaucoma filtration surgery
Human Tenon’s fibroblasts
Placental growth factor
Online Access:https://doi.org/10.1186/s12886-023-02914-4

Internet

https://doi.org/10.1186/s12886-023-02914-4

Similar Items